Miao Yuedong, Xie Fengnan, Cen Jiayu, Zhou Fei, Tao Xinfeng, Luo Jingfeng, Han Guocan, Kong Xianglei, Yang Xiaoming, Sun Jihong, Ling Jun
MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China.
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
ACS Macro Lett. 2018 Jun 19;7(6):693-698. doi: 10.1021/acsmacrolett.8b00287. Epub 2018 May 29.
α-Amino acid -thiocarboxyanhydrides (NTAs) are promising cyclic monomers to synthesize polypeptides and polypeptoids via controlled ring-opening polymerizations. Superior to -carboxyanhydrides requiring protection on hydroxyl groups, NTAs are able to tolerate such nucleophiles. In this work, we report the synthesis of NTA monomers containing unprotected phenolic hydroxyl groups of 3,4-dihydroxy-l-phenylalanine (DOPA) and l-tyrosine (Tyr). Their controlled ROPs and sequential copolymerizations with polysarcosine (PSar) yield PDOPA, PTyr, and PDOPA--polysarcosine (PDOPA--PSar) products quantitatively with designable degrees of polymerization. Micellar nanoparticles of Fe@PDOPA--PSar have been prepared thanks to the strong chelation of iron(III) cation by catechol ligands that act as T1-weighted magnetic resonance imaging (MRI) contrast agents. For instance, Fe@PDOPA--PSar exhibits higher longitudinal relaxivity ( = 5.6 mM s) than commercial Gd-based compounds. Effective MRI contrast enhancement in vivo of nude mice with a moderate duration (150 min) and 3D magnetic resonance angiography in rabbit illustrated by using volume rendering and maximal intensity projection techniques ignite the clinical application of Fe-based polypept(o)ides in diagnostic radiology as Gd-free MRI contrast agents.
α-氨基酸硫代羧酸酐(NTAs)是一类很有前景的环状单体,可通过可控的开环聚合反应合成多肽和聚肽模拟物。与需要对羟基进行保护的羧酸酐不同,NTAs能够耐受这类亲核试剂。在本工作中,我们报道了含有3,4-二羟基-L-苯丙氨酸(DOPA)和L-酪氨酸(Tyr)未保护酚羟基的NTA单体的合成。它们的可控开环聚合反应以及与聚肌氨酸(PSar)的顺序共聚反应能够定量地生成聚DOPA、聚Tyr和聚DOPA-聚肌氨酸(PDOPA-PSar)产物,且聚合度可设计。由于儿茶酚配体对铁(III)阳离子具有强螯合作用,已制备出Fe@PDOPA-PSar胶束纳米颗粒,这些配体可作为T1加权磁共振成像(MRI)造影剂。例如,Fe@PDOPA-PSar表现出比市售钆基化合物更高的纵向弛豫率( = 5.6 mM s)。通过使用体绘制和最大强度投影技术,在裸鼠体内实现了持续时间适中(150分钟)的有效MRI造影增强,以及在兔体内实现了3D磁共振血管造影,这激发了基于铁的多肽在诊断放射学中作为无钆MRI造影剂的临床应用。